RAGE Inhibition to Decrease Therapy Cardiotoxicity in Women With Early Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Cancer Related Cognitive Decline|Non-metastatic Breast Cancer
Interventions: DRUG: TTP488|DRUG: ddAC/ddT|DRUG: TC|DRUG: TCHP|DRUG: Chemotherapy regimen that includes ddAC
Sponsor: Georgetown University